IgA Nephropathy: What Is New in Treatment Options?
IgA nephropathy (IgAN), first described in 1968, is one of the most common forms of glomerulonephritis and can progress to end-stage kidney disease (ESKD) in 25 to 30 percent of patients within 20 to 25 years from the onset. It is histologically characterized by mesangial proliferation with prominen...
Saved in:
| Main Authors: | Roberto Scarpioni, Teresa Valsania |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Kidney and Dialysis |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-8236/4/4/19 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carboxymethyl-lysine is a Prominent Target of Circulating IgA in IgA Nephropathy
by: Sara Alibrandi, et al.
Published: (2025-07-01) -
Application of hydroxychloroquine for IgA nephropathy
by: Xiao Yong-zhen, et al.
Published: (2021-01-01) -
The effectiveness of a gluten-free diet in patients with IgA nephropathy
by: M. E. Mantsaeva, et al.
Published: (2023-04-01) -
Features of the diet in patients with IgA nephropathy and celiac antibodies in the blood
by: Mariya E. Mantsaeva, et al.
Published: (2024-03-01) -
HIV infection complicated with IgA nephropathy: one case report with a literature review
by: Liu Jing, et al.
Published: (2022-09-01)